Samsca (tolvaptan) Patient Assistance Program
Don’t let the high cost of brand hyponatremia therapy disrupt your treatment. We help eligible patients access Samsca (tolvaptan) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Samsca (tolvaptan) is FDA-approved for the treatment of clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and resistant to fluid restriction), including patients with heart failure and syndrome of inappropriate antidiuretic hormone (SIADH). Treatment must be initiated and re-initiated in a hospital setting due to risk of rapid sodium correction.
- Without assistance, brand Samsca costs commonly run approximately $300–$450 per tablet.
- Through AffordMyPrescriptions, qualifying patients can access Samsca for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic tolvaptan (Samsca generic) is now available in the U.S. at substantially lower cost. Note: Samsca is the hyponatremia formulation; Jynarque is the same drug for ADPKD (much higher doses and different REMS).
What Is Samsca Prescription Assistance Program?
The Samsca Prescription Assistance Program is a manufacturer-sponsored initiative that provides Samsca at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for patients with hyponatremia who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, hospitalist/nephrology/cardiology/endocrinology coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination.
Pharmacy Price Comparison
- Without assistance, Samsca costs roughly $300–$450 per tablet. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$430/tab | Save substantially |
| CVS Pharmacy (brand) | ~$450/tab | Save substantially |
| Walmart (brand) | ~$320/tab | Save substantially |
| Costco (brand) | ~$310/tab | Save substantially |
Generic tolvaptan | ~$80/tab | Generic — lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Samsca Prescription Program?
The Patient Assistance Program is free to apply for and provides Samsca at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic tolvaptan available at lower cost, generic is usually the cheaper path for most patients.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Samsca:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $300–$450/tab per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Samsca assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Samsca Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Samsca:
Samsca (tolvaptan) is a selective vasopressin V2 receptor antagonist used to treat clinically significant hyponatremia in hypervolemic or euvolemic conditions. By blocking V2 receptors in the kidney, Samsca causes aquaresis — excretion of free water without sodium — raising serum sodium back toward normal.
How Samsca Works:
Hypervolemic and euvolemic hyponatremia are driven by excessive water retention caused by elevated antidiuretic hormone activity. Tolvaptan treats this by selectively blocking V2 vasopressin receptors in the kidney collecting ducts, which prevents the insertion of aquaporin water channels. As a result, the kidneys become impermeable to water and excrete dilute urine, a process called aquaresis. This promotes free water excretion without losing sodium, effectively raising serum sodium levels.
Form and use:
Samsca is initiated in a hospital setting at 15 mg orally once daily, with serum sodium measured every 2 to 6 hours initially. The dose can be increased to 30 mg or 60 mg as needed, ensuring the maximum sodium correction stays below 12 mEq/L in any 24-hour period. After safe in-hospital initiation, patients can continue treatment as outpatients. However, therapy must be limited to a maximum duration of 30 days due to hepatotoxicity concerns, and any re-initiation requires a new hospital admission.
Generic availability:
Generic tolvaptan is currently available in the U.S. at a substantially lower cost than the brand-name Samsca. Other vasopressin receptor antagonists include conivaptan, which is restricted to intravenous hospital use, and the older generic drug demeclocycline. For managing chronic SIADH, lifestyle modifications like fluid restriction, salt tablets, and loop diuretics are often attempted first. Notably, the brand Jynarque also contains tolvaptan but features different dosing, is indicated for ADPKD, and has its own separate REMS program.
Warnings:
Samsca carries a Boxed Warning for severe, potentially fatal hepatotoxicity, requiring treatment to be limited to 30 days or less and avoiding use in patients with cirrhosis. It also carries a Boxed Warning for rapid sodium correction exceeding 12 mEq/L in 24 hours, which can cause osmotic demyelination syndrome and necessitates in-hospital monitoring. Additional warnings include risks of dehydration, hypotension, and volume depletion when combined with concurrent diuretics. Finally, patients must be monitored for hyperkalemia and significant drug interactions with CYP3A inhibitors and inducers.
FAQ (Frequently Asked Questions)
How Much Does Samsca Cost Without Insurance?
Brand Samsca costs approximately $300–$450 per tablet. Generic tolvaptan is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Samsca at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Was I Admitted To The Hospital To Start Samsca?
Samsca causes significant free water excretion and can correct sodium too quickly — overly rapid correction risks osmotic demyelination syndrome, a severe and sometimes irreversible neurologic disease. In-hospital initiation allows frequent sodium monitoring (every 2–6 hours initially) so the dose can be adjusted to keep correction safe (<12 mEq/L per 24 hours). Outpatient continuation is fine once safe in-hospital titration is complete.
How Long Will I Be On Samsca?
Samsca’s labeling limits total exposure to ≤30 days due to hepatotoxicity risk. For longer therapy, fluid restriction, salt tablets, loop diuretics, urea, or addressing the underlying cause (treating heart failure, evaluating SIADH cause) are alternatives. If the underlying condition causing hyponatremia is treatable (e.g., adjusting heart failure regimen), that is preferred over chronic Samsca.
Why Is My Liver Function Being Checked?
Tolvaptan can cause severe, sometimes fatal liver injury — the boxed warning. LFTs are monitored at baseline and during therapy. Significant transaminase elevations require stopping Samsca. Patients with underlying liver disease (especially cirrhosis) should not receive Samsca. The 30-day duration limit also reflects hepatotoxicity concern.
What About All The Urination?
Samsca causes ‘aquaresis’ — increased excretion of free water. You’ll urinate large volumes of dilute urine. Drink water freely whenever thirsty to prevent dehydration. This is the intended effect of the medication. Manage by anticipating frequent urination (plan bathroom access, avoid drinking immediately before sleep).
Are There Drug Interactions I Should Know About?
Yes. Strong CYP3A inhibitors (ketoconazole, clarithromycin, ritonavir) substantially raise tolvaptan levels — contraindicated. Strong CYP3A inducers (rifampin, carbamazepine, phenytoin, St. John’s wort) substantially lower levels. Other diuretics or RAAS inhibitors may potentiate volume depletion. Tell every prescriber and pharmacist about Samsca.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic tolvaptan (much cheaper), or to other hyponatremia management strategies (fluid restriction, salt tablets, urea, loop diuretics — addressing the underlying cause), the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Samsca, our team may be able to help you access assistance programs — or guide you to generic tolvaptan. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.